PIM
CNTA

Platinum Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Platinum Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137,741
Closed -$5.47M – 90
2026
Q1 		$5.47M Sell
137,741
-17,360
-11% -$444K 1.38% 20
2025
Q4 		$3.88M Sell
155,101
-31,298
-17% -$793K 0.9% 45
2025
Q3 		$4.52M Sell
186,399
-104,437
-36% -$1.86M 0.29% 41
2025
Q2 		$3.82M Buy
290,836
+22,949
+9% +$291K 0.25% 39
2025
Q1 		$3.85M Sell
267,887
-102,391
-28% -$1.68M 0.22% 34
2024
Q4 		$6.2M Sell
370,278
-59,423
-14% -$984K 0.36% 30
2024
Q3 		$6.87M Sell
429,701
-66,194
-13% -$811K 0.31% 31
2024
Q2 		$4.48M Buy
495,895
+10,721
+2% +$102K 0.18% 41
2024
Q1 		$5.48M Buy
485,174
+104,091
+27% +$986K 0.22% 39
2023
Q4 		$3.03M Buy
381,083
+43,539
+13% +$292K 0.12% 68
2023
Q3 		$2.18M Buy
337,544
+165,919
+97% +$1.14M 0.09% 78
2023
Q2 		$1.06M Buy
+171,625
New +$814K 0.04% 97

Platinum Investment Management's CNTA Position: Q2 2026 in Review

Platinum Investment Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 137,741 shares — an estimated $5.47M sold.

Platinum Investment Management first reported a position in CNTA in Q2 2023 and held it in 12 quarters. The position peaked at $6.87M in Q3 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • Platinum Investment Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Platinum Investment Management sold 137,741 Centessa Pharmaceuticals shares in Q2 2026, an estimated $5.47M.
  • Platinum Investment Management first reported a position in Centessa Pharmaceuticals in Q2 2023 and held it in 12 quarters.
  • Platinum Investment Management's Centessa Pharmaceuticals position peaked at $6.87M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Platinum Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.